DEF 14A

Company

LEXICON PHARMACEUTICALS, INC.

Filed

March 19, 2021

Period of Report

March 19, 2021

Accession Number

0001062822-21-000016

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →